PATENT CLAIM ANALYSIS

Application Number: 15975723
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "465000"]

Abstract:
Disclosed herein is, among other things, a soft gel vaginal pharmaceutical composition and dosage form containing solubilized estradiol for the treatment of vulvovaginal atrophy (VVA) and female sexual dysfunction (FSD).

Claim (Index 17):
The method of  claim 16 , wherein the estradiol is administered once daily for two weeks, then twice weekly thereafter.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 93.0
- Lexical Diversity: 1.12121
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893546', '15893542', '15372385', '15893550', '14521230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8581444168039201
- 35 USC 102 Novelty (BERT): 0.5732640988629009
- Combined Prediction Score: 0.8296563850098182
- Mean Citation Score: 623.065186
- Max Citation Score: 717.0466
- Similarity Product: 370.3790985274077

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test